Novo Holdings A/S 4
4 · MapLight Therapeutics, Inc. · Filed Oct 30, 2025
Insider Transaction Report
Form 4
Novo A/S
10% Owner
Transactions
- Conversion
Voting Common Stock
2025-10-28+2,733,681→ 2,733,681 total - Conversion
Series D Preferred Stock
2025-10-28−19,734,671→ 0 total→ Voting Common Stock (1,174,682 underlying) - Purchase
Voting Common Stock
2025-10-28$17.00/sh+952,941$16,199,997→ 3,686,622 total - Conversion
Series C Preferred Stock
2025-10-28−26,191,207→ 0 total→ Voting Common Stock (1,558,999 underlying)
Footnotes (2)
- [F1]The Series C Preferred Stock and Series D Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.
- [F2]Represents a purchase from the underwriters in the Issuer's initial public offering.